Kotra Industries Bhd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kotra Industries Bhd with three other
pharmaceutical manufacturers in Asia:
Gufic Biosciences Ltd
sales of 3.01 billion Indian Rupees [US$43.28 million]
of which 95%
CMG Pharmaceutical Co Ltd
of South Korea
(49.86 billion Korean Won [US$43.83 million]
of which 86%
was Tablet), and
DHP Korea Co Ltd
based in South Korea
(49.62 billion Korean Won [US$43.62 million]
of which 98%
was Finished Goods).
During the year ended June of 2018, sales at
Kotra Industries Bhd were 178.48 million Malaysian Ringgits (US$43.18 million).
increase of 7.3%
versus 2017, when the company's sales were 166.37 million Malaysian Ringgits.
This was the third consecutive year of growth at Kotra Industries Bhd.